LivaNova appoints Donald Zurbay to Board and Audit Committee

LivaNova PLC

Donald Zurbay appointed to LivaNova Board and Audit & Compliance Committee effective September 4, 2025.
Zurbay most recently President & CEO of Patterson Companies (Oct 2022-May 2025); previously CFO at Patterson and St. Jude Medical.
Compensation: $70k annual retainer, $15k audit committee fee, $185k annual restricted stock award, prorated until 2026 AGM.
No material transactions or arrangements between Zurbay and LivaNova per Item 404(a) review.

item 5.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.